ABSTRACT
Cases years and leads to increase in risk of hemorrhag of blood and blood products. There is a case presentation. Patient 23 years old. primigravida. Blood pathology was diagnosed in 2003. Platelets were 25.000-35.000 before pregnancy and about 6.000 during pregnancy. She was admitted to hospital and has treatment for 20 days and undergone Cesarean section and subtotal hysterectomy. She was discharged 11 days after operation with her baby. We could prevent severe pathology that would occur for mother with severe coagulation disorder by conducting treatment directed to improve platelets release, to inhibit phagocytes activities (immunoglobulin and steroids), to compensate coagulation disorders and blood product transfusions on the basis of laboratory analyses. These treatments made possible to perform surgery and severe pathology that could arise for newborn. Many times transfusion of different blood products were transfused safely. Mother delivered without complications and she had healthy baby.
ABSTRACT
|Introduction Cardiovascular disease is leading the mortality and morbidity not only in Mongolia but around the world. 148.2 million people were suffered from cardiovascular disease and 16.7 million mortality occurred in 2002, WHO Report. One of the main factors of cardiovascular disease's pathogenesis is the change in blood rheology value. As erythrocyte alone defines 67-X4% of the blood viscosity value we can study the erythrocyte characteristics representing rheology. Sialic acid provides the 60% of erythrocyte's surface negative charge which decrease in sialic acid will increases the aggregation rate. The aggregation reflects micro circulation disorder. During cardiovascular disease the micro circulation loss worsens the disease process however, as in Mongolia there is no possible way to determine micro circulation loss, thus this study has searched the new diagnostic possibility Material and methods All the participants have voluntarily partici''|d'C